A Study of Different Formulations of an A/H1N1 Pandemic Vaccine in Healthy Children Aged 6 Months to 9 Years

NCT00952419 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

474

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza
Swine-origin A/H1N1 Influenza

Interventions

BIOLOGICAL: Monovalent Subvirion A/H1N1 Influenza vaccine
BIOLOGICAL: Monovalent Subvirion A/H1N1 Influenza vaccine
BIOLOGICAL: Normal saline solution (placebo)

Sponsor

Sanofi Pasteur, a Sanofi Company